Sale of Majority Stake in FAMAR to MidEuropa by H ECM Partners and Metric Capital Partners
H ECM Partners and Metric Capital Partners have signed an agreement for the sale of the majority stake in FAMAR, a leading provider of pharmaceutical development and manufacturing services (CDMO), to MidEuropa. MidEuropa is a top private equity investor in Europe, having raised and managed funds exceeding 6 billion euros over its 25-year history.
Existing shareholders will retain stakes in FAMAR, reaffirming their long-term commitment and confidence in the company.
FAMAR Pharmaceuticals: A Leading Partner in the Pharmaceutical Industry
FAMAR is a key player in an extensive portfolio of top-tier pharmaceutical companies, operating in over 80 international markets. The company offers a full range of value chain services of CDMOs with expanded production capabilities in multiple dosage forms, including sterile, solid, semi-solid types, as well as Research & Development services.
FAMAR has six production units in southern Europe and two Research & Development centers, employing around? individuals. The company’s expertise and innovative approach make it a trusted partner for pharmaceutical companies looking to expand their horizons and reach new markets.
Expanding FAMAR’s Reach
FAMAR, a leading CDMO in Europe, with 1,900 employees, is expressing gratitude towards ECM and Metric for their collaboration over the past four years. Konstantinos Reggis, CEO of FAMAR, acknowledges the investments, support, and guidance provided by ECM and Metric as instrumental in establishing FAMAR as a key player in the CDMO market in Europe.
The excitement continues as FAMAR announces a new partnership with MidEuropa to further expand their presence and solidify their position as a top CDMO service platform globally. The goal is to continue growing and evolving FAMAR into a world-class leader in CDMO services.
Expanding Horizons: FAMAR’s New Chapter
Peter Prock, current President of the FAMAR Board of Directors, expressed his excitement for the company’s new chapter in global development. “I am particularly happy to see FAMAR opening a new chapter as part of their growth journey. I look forward to supporting the company’s Management Team and MidEuropa in their journey to enter new markets and continue to offer their services to their clients, as well as to a broader community,” he stated.
Savvas Liasis, President of the Board of Directors, also shared his enthusiasm for FAMAR’s expansion plans. “This marks a significant milestone for the company, and I am confident that their dedication to health and well-being will benefit millions of patients worldwide,” he added.
FAMAR: A Leading CDMO in Pharmaceutical Industry
When we decided to participate in their shareholding in 2020, what we noticed about FAMAR was the character of a company that operates with high quality standards and maintains a long tradition of customer service in the pharmaceutical industry. Through extensive efforts, we managed to expand their portfolio and drive growth by making investments with a special focus on Research & Development. Today, FAMAR is one of the top CDMOs with capabilities and quality of services worldwide.
Exciting News for FAMAR
The company FAMAR has recently been sold to MidEuropa, a leading investment firm. This acquisition is expected to bring new opportunities for FAMAR and its talented management team.
John Sinik, Managing Partner at Metric Capital Partners, expressed his happiness about the sale, congratulating FAMAR’s management team for their significant achievements over the past four years. Under the guidance of MidEuropa, FAMAR is expected to continue thriving in the next phase of its development.
Expanding Business Opportunities in Europe
Our company is excited to announce its continued growth and expansion into new and exciting sectors in Europe. With the support of MidEuropa, we are confident that we will thrive in this diverse market.
Strategic Partnerships for Success
Jefferies has acted as the exclusive financial advisor for FAMAR, while Reed Smith and Papapolitis & Papapolitis have provided legal counsel for the sale. Rothschild & Co and AXIA Ventures Group have served as financial advisors for Mergers & Acquisitions and Debt Management for MidEuropa, with DLA Piper providing legal advice for the acquisition. The transaction is subject to customary terms and approvals.
The benefits of practicing yoga
Yoga is a popular form of exercise that not only benefits the body but also the mind and soul. Regular practice of yoga can help improve flexibility, strength, and balance. It also promotes relaxation and reduces stress levels, which can have a positive impact on overall well-being.
In addition to physical benefits, yoga is also known to improve mental clarity and focus. The breathing techniques and meditation involved in yoga practice can help calm the mind and improve concentration. Many people find that practicing yoga regularly leads to a greater sense of inner peace and emotional well-being.
Furthermore, yoga is a versatile form of exercise that can be adapted to suit individuals of all ages and fitness levels. Whether you are a beginner or an experienced yogi, there are various styles and levels of yoga that can cater to your needs and goals. With consistent practice, you can experience the many benefits that yoga has to offer for your body, mind, and soul.
